Literature DB >> 22086789

High levels of hsCRP are associated with carbohydrate metabolism disorder.

Elba Leiva1, Verónica Mujica, Katherine Brito, Ivan Palomo, Roxana Orrego, Rodrigo Moore-Carrasco, Marcela Vásquez, Luis Guzmán, Sergio Nuñez, Nora Díaz, Gloria Icaza, Miguel Arredondo.   

Abstract

AIM: To determine risk parameters associated with high values of high sensitive C-reactive protein (hsCRP) in subjects with different glucose fasting levels.
METHODS: Anthropometric parameters, arterial pressure, glycemia, lipid profile, uric acid, and hsCRP were studied in a population of 513 individuals between 40 and 65 years.
RESULTS: In total, 349 (68.0%) were normoglycemic (NG); 113 (22.0%) had impaired fasting glucose (IFG); and 51 (9.9%) were diabetic subjects. A multivariate linear regression analysis showed that the natural logarithm of hsCRP was associated significantly with glycemia levels (P = 0.009), uric acid (P = 0.001), diastolic blood pressure (P = 0.011), smoking habit (P = 0.021), BMI (P<0.001), and sex (P<0.001). One-third of the NG subjects had high hsCRP levels. A multiple logistic regression analysis showed that sex and BMI were variables related to high levels of hsCRP in subjects with IFG and NG. In NG subjects, uric acid levels were associated with risk of presenting high hsCRP levels and were higher in women than men. In NG women, ROC curves analysis identified a uric acid level of 3.9  mg/dl as a cut-off point to predict a high value of hsCRP. Those individuals with uric acid values higher than 3.9 mg/dl and normal glycemia had 3.5-fold more risk of having hsCRP levels over 3.0 mg/l.
CONCLUSIONS: We sustain that high levels of hsCRP are associated with disturbance in carbohydrate metabolism. In addition, we believe that in low cardiovascular risk population, such as NG women, uric acid levels above 3.9 mg/dl might represent a signal of possible pro-inflammatory state and cardiovascular risk.
© 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22086789      PMCID: PMC6647569          DOI: 10.1002/jcla.20455

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  25 in total

1.  Increased levels of C-reactive protein and fibrinogen influence the risk of vascular events in patients with NIDDM.

Authors:  Giuseppe Coppola; Egle Corrado; Ida Muratori; Rosalba Tantillo; Giustina Vitale; L Lo Coco; Salvatore Novo
Journal:  Int J Cardiol       Date:  2006-01-04       Impact factor: 4.164

2.  Diagnosis and classification of diabetes mellitus.

Authors: 
Journal:  Diabetes Care       Date:  2008-01       Impact factor: 19.112

Review 3.  Acute-phase proteins and other systemic responses to inflammation.

Authors:  C Gabay; I Kushner
Journal:  N Engl J Med       Date:  1999-02-11       Impact factor: 91.245

4.  The optimal cut-off point of C-reactive protein as an optional component of metabolic syndrome in Japan.

Authors:  Eiji Oda; Kazuhiko Oohara; Akihiro Abe; Punniyakoti T Veeraveedu; Kenichi Watanabe; Kiminori Kato; Yoshifusa Aizawa
Journal:  Circ J       Date:  2006-04       Impact factor: 2.993

5.  Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study.

Authors:  Anthony J G Hanley; Ken Williams; Andreas Festa; Lynne E Wagenknecht; Ralph B D'Agostino; Steven M Haffner
Journal:  Diabetes       Date:  2005-11       Impact factor: 9.461

6.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

7.  Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker.

Authors:  Sridevi Devaraj; Grant O'Keefe; Ishwarlal Jialal
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

Review 8.  Postprandial peaks as a risk factor for cardiovascular disease: epidemiological perspectives.

Authors:  Enzo Bonora
Journal:  Int J Clin Pract Suppl       Date:  2002-07

9.  Prospective study of high-sensitivity C-reactive protein as a determinant of mortality: results from the MONICA/KORA Augsburg Cohort Study, 1984-1998.

Authors:  Wolfgang Koenig; Natalie Khuseyinova; Jens Baumert; Christa Meisinger
Journal:  Clin Chem       Date:  2007-12-21       Impact factor: 8.327

10.  C-reactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases.

Authors:  Jian-Jun Li; Chun-Hong Fang
Journal:  Med Hypotheses       Date:  2004       Impact factor: 1.538

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.